Inari Medical Leadership & Management in Irvine

Key Insight for Candidates

• Strategic Vision & Planning: In Irvine, leaders articulate a clear, consistent direction centered on VTE leadership, adjacent therapies, and international expansion, which continued after the acquisition by Stryker. Feedback suggests integration has clarified how the portfolio fits within Stryker’s endovascular strategy.
• Strong Execution: Irvine teams see leadership deepening the commercial and medical bench to drive execution and clinician education, including adding a senior U.S. sales leader and a VP of Medical Affairs. Evidence-led launches and trial progress are tied to concrete milestones and product rollouts.
• Empowering Team Culture: Colleagues in Irvine are often seen as mission-driven with strong camaraderie, reinforcing a sense of purpose in day-to-day work. The headquarters’ open, highly communicative setup is intended to promote collaboration across teams.

• Lack of Transparency & Communication: In Irvine, some observe uneven transparency and leadership consistency, with reduced line‑of‑sight into program prioritization and spending cadence as integration into Stryker reshapes reporting. Integration changes are noted to affect priorities and decision speed.
• Lack of Development & Mentorship: Irvine employees have reported variability in middle‑management quality and training, leading to inconsistent day‑to‑day experiences across teams. This unevenness can dilute coaching and support despite an otherwise seasoned senior bench.
• Toxic or Disempowering Culture: Sales‑adjacent roles in Irvine are described as operating under intense pressure, which can strain the local culture. The hard‑charging pace creates stress that not all teams experience equally.